期刊文献+

曲古霉素A对SGC7901/ADR细胞系耐药逆转机制的研究 被引量:1

Effect of TSA on the drug-resistance reversion in SGC7901/ADR
下载PDF
导出
摘要 目的观察组蛋白去乙酰酶抑制剂曲古霉素A(trichostain,TSA)对体外培养胃癌耐药细胞SGC7901/ADR是否具有逆转耐药的作用,并对其作用机制进行探讨。方法①MTT法计算出胃癌耐药细胞SGC7901/ADR的耐药倍数及TSA作用后的逆转倍数。②分空白组、1.5 nmol/L TSA组和12 nmol/L TSA组,依次作用48 h和72 h,用流式细胞仪检测胃癌耐药细胞内阿霉素(adriacin,ADR)浓度。RT-PCR法检测耐药细胞内MDR1(multidrug resistance)基因表达。结果 TSA对胃癌耐药细胞SGC7901/ADR有明显逆转作用,MTT法计算出SGC7901/ADR细胞的耐药倍数是29.51倍,TSA作用后逆转倍数约为1.95倍,流式细胞仪检测TSA作用后胃癌耐药细胞内阿霉素浓度明显增加,且呈时间剂量依赖性,RT-PCR法检测TSA作用后耐药细胞内MDR1基因表达明显降低。结论 TSA对胃癌耐药细胞SGC7901/ADR具有明显逆转作用,可能是通过下调MDR1的表达,增加细胞内ADR浓度实现的。 Objective To investigate the reversal effect of trichostain A(TSA),a histone deacetylase inhibitor,in the gastric cancer in vitro,and to explore its mechanism.Methods ①MTT assay was used to calculate the drug-resistance index of the SGC7901/ADR and the reversion drug-resistance index after giving TSA.②The cells were divided into blank group,1.5 nmol/L TSA group,and 12 nmol/L TSA group.The cells were treated respectively for 48 h and 72 h.Then the flow cytometer was used to detect the adriacin(ADR) density in the SGC7901/ADR.RT-PCR was employed to detect the MDR1 gene expression in the SGC7901.Results TSA exerted obvious reversion effects on the SGC7901/ADR.The drug-resistance index obtained by MTT method was 29.51,and the reversion drug-resistance index after giving TSA was 1.95.Flow cytometry results showed that the adriacin density in the SGC7901/ADR obviously increased after giving TSA in a time-and dose-dependent manner.RT-PCR results showed that the MDR1 gene expression in the SGC7901/ADR obviously decreased after giving TSA.Conclusion TSA has a distinct reversion drug-resistance effect on the SGC7901/ADR,which may be implemented by downregulating the MDR1 gene expression and increasing the ADR density in the SGC7901/ADR.
出处 《山西医科大学学报》 CAS 2013年第3期185-188,共4页 Journal of Shanxi Medical University
关键词 TSA 胃癌 多药耐药 MDR1基因 trichostain gastric cancer multidrug resistance MDR1 gene
  • 相关文献

参考文献6

二级参考文献57

共引文献20

同被引文献10

  • 1常宏宇,潘凯丽,马福成,焦西英,朱华锋,刘建红,黄莹,曹玉红.姜黄素、红霉素逆转K562/A02细胞多药耐药机制的研究[J].中华血液学杂志,2006,27(4):254-258. 被引量:14
  • 2Noorafshan AS, Ashkani-Esfahani S. A review of ther- apeutic effects of curcumin [ J ]. Curt Pharm Design, 2013, 19( ll ) : 2032-2046.
  • 3Szakacs G, Paterson JK, Ludwig JA, et al. Targeting multidrug resistance in cancer[J]. Nat Rev Drug Dis- cov, 2006, 5 (3) : 219-234.
  • 4Juan H, Jing T, Hua-Wan Y, et al. P-gp induction by curcumin: an effective antidotal pathway [ J]. J Bio- equiv Availab, 2013, 5(6): 236-241.
  • 5Lu WD, Qin Y, Chuang Y, et al. Effect of curcumin on human colon cancer muhidrug resistance in vitro and in vivo[J]. Clinics, 2013, 68(5): 694-701.
  • 6Kunnumakkara AB, Anand P, Aggarwal BB. Curcu- min inhibits proliferation, invasion, angiogenesis and metastasis of different cancers through interaction with multiple cell signaling proteins [ J ]. Cancer Lett, 2008, 269(2) : 199-225.
  • 7Prakobwong S, Gupta SC, Kim JH, et al. Curcumin suppresses proliferation and induces apoptosis in hu- man biliary cancer cells through modulation of multiple cell signaling pathways [ J ]. Carcinogenesis, 2011, 32 (9) : 1372-1380.
  • 8Sen GS, Mohanty S, Hossain DMS, et al. Curcumin enhances the efficacy of chemotherapy by tailoring p65NFKB-p300 cross-talk in favor of p53-p300 in breast cancer [ J ]. J Biol 42232-42247.
  • 9Kantharidis P, E1-Osta A, Chem, 2011, 286 (49 : deSilva M, et al. Altered methylation of the human MDR1 promoter is associated with acquired muhidrug resistance [ J ]. Clin Cancer Res, 1997, 3(11): 2025-2032.
  • 10Link A, Balaguer F, Shen Y, et al. Curcumin modu- lates DNA methylation in colorectal cancer cells [ J ]. PLoS One, 2013, 8(2) : e57709.

引证文献1

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部